Biosergen AB's total assets for Q2 2026 were kr10.24M, a decrease of 0.00% from the previous quarter. DE:8N10 total liabilities were kr9.53M for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.